67 studies found for:    "Pilocytic astrocytoma"
Show Display Options
Rank Status Study
21 Completed Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer
Conditions: Brain and Central Nervous System Tumors;   Intraocular Melanoma;   Lung Cancer;   Melanoma (Skin);   Neuroblastoma;   Retinoblastoma;   Sarcoma
Intervention: Radiation: iodine I 131 monoclonal antibody 3F8
22 Completed Study of Blood Samples and Risk of Infection in Patients With Newly Diagnosed Malignant Supratentorial Astrocytoma
Conditions: Brain and Central Nervous System Tumors;   Infection
Interventions: Other: laboratory biomarker analysis;   Other: questionnaire administration
23 Active, not recruiting Study of Blood and Cheek Cell Samples From Patients With Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Other: medical chart review
24 Completed Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide;   Genetic: protein expression analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: diagnostic laboratory biomarker analysis;   Other: immunoenzyme technique
25 Recruiting Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Conditions: Brain and Central Nervous System Tumors;   Intraocular Melanoma;   Lung Cancer;   Melanoma (Skin);   Metastatic Cancer;   Neuroblastoma;   Ovarian Cancer;   Retinoblastoma;   Sarcoma;   Small Intestine Cancer
Interventions: Genetic: DNA analysis;   Other: immunologic technique;   Other: pharmacological study;   Radiation: iodine I 131 monoclonal antibody 3F8;   Radiation: 131I-3F8
26 Completed Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors
Conditions: Adrenocortical Carcinoma;   Brain and Central Nervous System Tumors;   Head and Neck Cancer;   Liver Cancer;   Malignant Mesothelioma;   Pheochromocytoma;   Sarcoma
Interventions: Drug: cisplatin;   Drug: doxorubicin hydrochloride;   Drug: tamoxifen citrate;   Procedure: conventional surgery;   Radiation: radiation therapy
27 Terminated Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors
Conditions: Brain and Central Nervous System Tumors;   Cognitive/Functional Effects;   Depression;   Fatigue;   Quality of Life
Interventions: Drug: methylphenidate hydrochloride;   Procedure: quality-of-life assessment;   Radiation: radiation therapy
28 Completed Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors
Conditions: Brain and Central Nervous System Tumors;   Chemotherapeutic Agent Toxicity;   Infertility
Intervention:
29 Completed Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors
Conditions: Brain and Central Nervous System Tumors;   Metastatic Cancer;   Neuroblastoma
Interventions: Procedure: surgical procedure;   Radiation: astatine At 211 monoclonal antibody 81C6
30 Completed Donepezil or EGb761 in Improving Neurocognitive Function in Patients Who Have Previously Undergone Radiation Therapy for Primary Brain Tumor or Brain Metastases
Conditions: Brain and Central Nervous System Tumors;   Radiation Toxicity
Interventions: Dietary Supplement: EGb761;   Drug: donepezil hydrochloride;   Procedure: cognitive assessment
31 Completed Imatinib Mesylate in Treating Patients With Gliomas
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: imatinib mesylate
32 Completed Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors
Conditions: Brain and Central Nervous System Tumors;   Cognitive/Functional Effects;   Fatigue;   Metastatic Cancer;   Psychosocial Effects of Cancer and Its Treatment;   Radiation Toxicity
Interventions: Drug: donepezil hydrochloride;   Other: placebo
33 Completed Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer
Conditions: Brain and Central Nervous System Tumors;   Breast Cancer;   Gastrointestinal Carcinoid Tumor;   Islet Cell Tumor;   Lung Cancer;   Lymphoma;   Melanoma (Skin);   Neoplastic Syndrome
Intervention: Radiation: yttrium Y 90-edotreotide
34 Withdrawn Perfusion Magnetic Resonance Imaging in Measuring the Growth of Blood Vessels in Newly Diagnosed Brain Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Other: laboratory biomarker analysis;   Procedure: biopsy;   Procedure: magnetic resonance imaging;   Radiation: gadopentetate dimeglumine
35 Recruiting Bevacizumab in Recurrent Grade II and III Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Biological: Bevacizumab;   Drug: Temozolomide
36 Completed Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: carmustine;   Drug: polifeprosan 20 with carmustine implant;   Procedure: surgical procedure
37 Terminated Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Conditions: Brain and Central Nervous System Tumors;   Lymphoma;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Biological: filgrastim;   Biological: sargramostim;   Biological: therapeutic autologous lymphocytes;   Drug: O6-benzylguanine;   Drug: carmustine;   Drug: temozolomide;   Procedure: in vitro-treated peripheral blood stem cell transplantation
38 Completed Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Evaluating Patients Who Are Undergoing Treatment for Gliomas
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: chemotherapy;   Procedure: conventional surgery;   Procedure: magnetic resonance imaging;   Procedure: magnetic resonance spectroscopic imaging;   Radiation: radiation therapy
39 Completed Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment
Conditions: Brain and Central Nervous System Tumors;   Lymphoma;   Metastatic Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: bortezomib;   Drug: temozolomide;   Other: pharmacological study
40 Completed Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors
Conditions: Brain and Central Nervous System Tumors;   Neuroblastoma
Interventions: Drug: carmustine;   Drug: irinotecan hydrochloride;   Procedure: surgical procedure;   Radiation: iodine I 131 monoclonal antibody 81C6

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years